Weight management performed very inconsistently over the review period. Although consumers became increasingly self-conscious, the economic crisis led to the category underperforming for several years. In 2014, the withdrawal of Alli, the only OTC obesity product available in the Netherlands at that time, caused the category to underperform during the year.
Euromonitor International's Weight Management in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.
Product coverage: Meal Replacement Slimming, OTC Obesity, Other Slimming Products, Slimming Teas, Weight Loss Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Weight Management market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
65 pages •
By Euromonitor International
• Mar 2021
This report analyses the market for consumer health in Cambodia. For the purposes of the study, the market has been defined as follows:
Consumer Health in Cambodia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify...
111 pages •
By Euromonitor International
• Jan 2021
The emergence of the pandemic in Colombia and subsequent lockdown by the government in an attempt to control the spread of the virus resulted in rising unemployment and decreasing disposable incomes, and led to many local consumers prioritising their spending on essential purchases, including groceries and medicines. Consumer health therefore,...
119 pages •
By Euromonitor International
• Jan 2021
Consumer health has seen slightly higher growth overall in current value terms in 2020 compared to the previous year. Nevertheless, growth has remained largely in line with the review period average, with economic pressures preventing any more significant gains. When COVID-19 first appeared in South Africa there was some initial stockpiling...
116 pages •
By Euromonitor International
• Jan 2021
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
119 pages •
By Euromonitor International
• Jan 2021
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
110 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see slower current value growth in 2020 than was seen the previous year. One of the factors dictating growth in this year is expected to be COVID-19. As news about the virus emerged in the country, consumers began panic-buying at the start of quarter two of 2020, stockpiling certain consumer health products,...
215 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
125 pages •
By Euromonitor International
• Dec 2020
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
110 pages •
By Euromonitor International
• Nov 2020
The Czech consumer health market is expected to witness a slightly improved year-on-year performance in 2020 as the COVID-19 pandemic has boosted demand across a number of categories. In the face of the pandemic, consumers have sought products that are thought to enhance the working of the immune system, positively impacting sales in a number...
91 pages •
By Euromonitor International
• Nov 2020
The main developments in consumer health in Costa Rica in 2020 as a result of COVID-19 are related to the sudden spike in the sales of vitamins and dietary supplements, particularly those associated to immunity responses. For example, echinacea has gained significant awareness amongst local consumers in 2020. COVID-19 resulted in shortages...
OTC
Dietary Supplement
Healthcare
Vitamin
Costa Rica
World
Analgesic Medicine Sales
Vitamin Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.